Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab and Teriparatide for Atraumatic Bone Marrow Edema
NCT01734824Phase 4Suspended
- Sponsor
- Medical University of Vienna
- Start
- May 2012
- Primary completion
- Sep 2015
- Modality
- Antibody Conjugates, Recombinant Proteins and Enzymes, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab, teriparatide in bone marrow edema syndrome (BMES), sponsored by Medical University of Vienna. Started May 2012; status: suspended.
02
Drugs
denosumabteriparatide
03
Conditions
bone marrow edema syndrome (BMES)
Beyond the preview
Go deeper on NCT01734824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01734824.